125 related articles for article (PubMed ID: 2185111)
1. Decreased VIP content in peripheral nerve from streptozocin-induced diabetic rats.
Noda K; Umeda F; Ono H; Hisatomi A; Chijiiwa Y; Nawata H; Ibayashi H
Diabetes; 1990 May; 39(5):608-12. PubMed ID: 2185111
[TBL] [Abstract][Full Text] [Related]
2. Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits.
Pop-Busui R; Sullivan KA; Van Huysen C; Bayer L; Cao X; Towns R; Stevens MJ
Exp Neurol; 2001 Apr; 168(2):259-72. PubMed ID: 11259114
[TBL] [Abstract][Full Text] [Related]
3. Impaired induction of vasoactive intestinal polypeptide after sciatic nerve injury in the streptozotocin-diabetic rat.
Calcutt NA; Mizisin AP; Yaksh TL
J Neurol Sci; 1993 Nov; 119(2):154-61. PubMed ID: 8277329
[TBL] [Abstract][Full Text] [Related]
4. Effect of ropivacaine on peripheral neuropathy in streptozocin diabetes-induced rats through TRPV1-CGRP pathway.
Zhang N; Wei H; Wu W; Lin P; Chen Y; Liu Z; Wang H; Bian Y; Yu K; Lin S; Cui Y; Luo R; Lin J; Chen X
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31661547
[TBL] [Abstract][Full Text] [Related]
5. Substance P and somatostatin content and transport in vagus and sciatic nerves of the streptozocin-induced diabetic rat.
MacLean DB
Diabetes; 1987 Mar; 36(3):390-5. PubMed ID: 2433176
[TBL] [Abstract][Full Text] [Related]
6. Water content, vasoactive intestinal polypeptide and substance P in intact and crushed sciatic nerves of normal and streptozotocin-diabetic rats.
Anand P; Llewelyn JG; Thomas PK; Gillon KR; Lisk R; Bloom SR
J Neurol Sci; 1988 Feb; 83(2-3):167-77. PubMed ID: 2451710
[TBL] [Abstract][Full Text] [Related]
7. Effect of aldose reductase inhibition on nerve conduction velocity and resistance to ischemic conduction block in experimental diabetes.
Price DE; Airey CM; Alani SM; Wales JK
Diabetes; 1988 Jul; 37(7):969-73. PubMed ID: 3133261
[TBL] [Abstract][Full Text] [Related]
8. Establishment of a rat model of type II diabetic neuropathic pain.
Dang JK; Wu Y; Cao H; Meng B; Huang CC; Chen G; Li J; Song XJ; Lian QQ
Pain Med; 2014 Apr; 15(4):637-46. PubMed ID: 24716590
[TBL] [Abstract][Full Text] [Related]
9. Effect of aldose reductase inhibitor ONO 2235 on reduced sympathetic nervous system activity and peripheral nerve disorders in STZ-induced diabetic rats.
Yoshida T; Nishioka H; Yoshioka K; Nakano K; Kondo M; Terashima H
Diabetes; 1987 Jan; 36(1):6-13. PubMed ID: 3025043
[TBL] [Abstract][Full Text] [Related]
10. Insulin resistance occurs in parallel with sensory neuropathy in streptozotocin-induced diabetes in rats: differential response to early vs late insulin supplementation.
Szilvássy Z; Németh J; Kovács P; Paragh G; Sári R; Vígh L; Peitl B
Metabolism; 2012 Jun; 61(6):776-86. PubMed ID: 22154324
[TBL] [Abstract][Full Text] [Related]
11. Effects of chronic alpha-adrenergic receptor blockade on peripheral nerve conduction, hypoxic resistance, polyols, Na(+)-K(+)-ATPase activity, and vascular supply in STZ-D rats.
Cameron NE; Cotter MA; Ferguson K; Robertson S; Radcliffe MA
Diabetes; 1991 Dec; 40(12):1652-8. PubMed ID: 1661693
[TBL] [Abstract][Full Text] [Related]
12. Mechanical hyperalgesia correlates with insulin deficiency in normoglycemic streptozotocin-treated rats.
Romanovsky D; Cruz NF; Dienel GA; Dobretsov M
Neurobiol Dis; 2006 Nov; 24(2):384-94. PubMed ID: 16935517
[TBL] [Abstract][Full Text] [Related]
13. Effects of Low-Intensity Treadmill Exercise on Sciatic Nerve in Experimental Diabetic Neuropathy.
Gulsen I; Demiroglu M; Aycan A; Ucler R; Alaca I; Orhon ZN; Kanter M
Anal Quant Cytopathol Histpathol; 2016 Apr; 38(2):95-102. PubMed ID: 27386630
[TBL] [Abstract][Full Text] [Related]
14. Sex differences in the manifestation of peripheral diabetic neuropathy in gonadectomized rats: a correlation with the levels of neuroactive steroids in the sciatic nerve.
Pesaresi M; Giatti S; Cavaletti G; Abbiati F; Calabrese D; Bianchi R; Caruso D; Garcia-Segura LM; Melcangi RC
Exp Neurol; 2011 Apr; 228(2):215-21. PubMed ID: 21241692
[TBL] [Abstract][Full Text] [Related]
15. Diabetes mellitus is associated with a decrease in vasoactive intestinal polypeptide content of gastrointestinal tract of rat.
Adeghate E; Ponery AS; Sharma AK; El-Sharkawy T; Donáth T
Arch Physiol Biochem; 2001 Jul; 109(3):246-51. PubMed ID: 11880929
[TBL] [Abstract][Full Text] [Related]
16. Axonal transport of endogenous nerve growth factor (NGF) and NGF receptor in experimental diabetic neuropathy.
Hellweg R; Raivich G; Hartung HD; Hock C; Kreutzberg GW
Exp Neurol; 1994 Nov; 130(1):24-30. PubMed ID: 7821393
[TBL] [Abstract][Full Text] [Related]
17. Role of A3 adenosine receptor in diabetic neuropathy.
Yan H; Zhang E; Feng C; Zhao X
J Neurosci Res; 2016 Oct; 94(10):936-46. PubMed ID: 27319979
[TBL] [Abstract][Full Text] [Related]
18. Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy.
Hellweg R; Hartung HD
J Neurosci Res; 1990 Jun; 26(2):258-67. PubMed ID: 2142224
[TBL] [Abstract][Full Text] [Related]
19. Acetyl-L-carnitine prevents substance P loss in the sciatic nerve and lumbar spinal cord of diabetic animals.
Di Giulio AM; Gorio A; Bertelli A; Mantegazza P; Ferraris L; Ramacci MT
Int J Clin Pharmacol Res; 1992; 12(5-6):243-6. PubMed ID: 1284499
[TBL] [Abstract][Full Text] [Related]
20. Reduction of cyclic AMP in the sciatic nerve of rats made diabetic with streptozotocin and the mechanism involved.
Shindo H; Tawata M; Onaya T
J Endocrinol; 1993 Mar; 136(3):431-8. PubMed ID: 7682591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
